praxbind
boehringer ingelheim international gmbh - idarucizumab - krvácanie - všetky ostatné terapeutické produkty - praxbind je špecifické storno agent pre dabigatran a je indikovaný u dospelých pacientov liečených pradaxa (dabigatran etexilate), keď rýchly zvrat jeho anticoagulant účinky, je potrebné:pre núdzové operáciu/urgentné postupy;v život ohrozujúcich alebo nekontrolované krvácanie.
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - viacnásobný myelóm - antineoplastické činidlá - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
suprax
gedeon richter plc., maďarsko - cefixím - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
suprax
gedeon richter plc., maďarsko - cefixím - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
suprax 400 mg dispergovateľné tablety
gedeon richter plc., maďarsko - cefixím - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
relpax 20 mg
upjohn eesv, holandsko - eletriptán - 33 - antimigraenica,antiserotonica
relpax 40 mg
upjohn eesv, holandsko - eletriptán - 33 - antimigraenica,antiserotonica
relpax 80 mg
upjohn eesv, holandsko - eletriptán - 33 - antimigraenica,antiserotonica